January 1, 2021
Uniformed Services University (USU) has been awarded a $1,573,373.00 federal grant from the Congressionally Directed Medical Research Programs (CDMRP) to support research aimed at improving battlefield medicine. The grant, led by Dr. David Burmeister, Principal Investigator (PI), will fund evaluation of SiOxMed’s Silicon-Based Polymer Universal Combat Matrix (UCM), a promising new medical technology designed to address severe bleeding and burns on the battlefield.
About the Project
The funding will be used to conduct advanced testing of the UCM in preclinical models, specifically focusing on hemorrhage control and burn treatment in large animal models. The studies will evaluate UCM’s ability to stop bleeding and promote tissue regeneration, which are essential for treating battlefield injuries where traditional methods are less effective.
Swine models will be used to replicate real-world injuries, providing researchers with key insights into the UCM’s performance in scenarios similar to those encountered in military settings. The results from these studies will guide the next phase of product development and testing.
Next Steps
SiOxMed will continue to test the UCM’s effectiveness in preclinical animal models for regulatory clearance, with plans for clinical trials in the future. The ultimate goal is to refine and optimize UCM for use in both military and civilian emergency settings, where it can make a critical difference in saving lives.
Learn more
